Table 2.

Distribution of level of evidence in each topic.

Topic	LOE A N (%)	LOE B N (%)	LOE C N (%)	Total
Chest pain [5]	0 (0 %)	9 (53 %)	8 (47 %)	17
B-Blockers [8]	28 (43 %)	16 (25 %)	21 (32 %)	65
ACEI [9]	12 (86 %)	1 (7 %)	1 (7 %)	14
Antiplatelets [10]	22 (81 %)	3 (12 %)	2 (7 %)	27
Endomyocardial biopsy [11]	0 (0 %)	3 (21 %)	11 (79 %)	14
Device therapy [12]	2 (25 %)	3 (37.5 %)	3(37.5 %)	8
Aortic disease [13]	4 (3 %)	18 (15 %)	99 (82 %)	121
HCM [14]	0 (0 %)	36 (28 %)	94 (72 %)	130
IE [15]	1 (1 %)	29 (38 %)	46 (61 %)	76
Pericardial disease [16]	6 (5 %)	28 (21 %)	99 (74 %)	133
STEMI [17]	65 (31 %)	74 (35 %)	73 (34 %)	212
DAPT [18]	24 (30 %)	35 (44 %)	21 (26 %)	80
PAD [19]	36 (19 %)	56 (29 %)	98 (52 %)	190
CVD during pregnancy [20]	2 (1.3 %)	11 (7.4 %)	136 (91.3 %)	149
Hypertension [21]	49 (36.3 %)	39 (28.9 %)	47 (34.8 %)	135
Revascularization [22]	60 (25.2 %)	82 (34.5 %)	96 (40.3 %)	238
Syncope [23]	5 (4.4 %)	51 (44.7 %)	58 (50.9 %)	114
SVT [24]	2 (1.6 %)	65 (53.3 %)	55 (45.1 %)	122
Pulmonary Embolism [25]	16 (21 %)	29 (38.2 %)	31 (40.8 %)	76
Chronic Coronary Syndrome [26]	45 (28.5 %)	55 (34.8 %)	58 (36.7 %)	158
Dyslipidemia [27]	19 (27.9 %)	13 (19.1 %)	36 (53 %)	68
Diabetes [28]	59 (43.7 %)	36 (26.7 %)	40 (29.6 %)	135
Atrial Fibrillation [29]	23 (18.4 %)	64 (51.2 %)	38 (30.4 %)	125
Sports [30]	13 (8.1 %)	23 (14.3 %)	125 (77.6 %)	161
NSTEMI [31]	23 (18.3)	68 (54 %)	35 (27.7 %)	126
Adult Congenital heart disease [32]	1 (0.7 %)	3 (2.2 %)	131 (97.1 %)	135
CVD Prevention [33]	65 (36.9 %)	68 (38.6 %)	43 (24.5 %)	176
Cardiac Pacing & CRT [34]	13 (10.8 %)	36 (30 %)	71 (59.2 %)	120
Valvular Heart Disease [35]	4 (3.4 %)	45 (37.8 %)	70 (58.8 %)	119
Heart Failure [36]	25 (20.7 %)	38 (31.4 %)	58 (47.9 %)	121
Cardio-oncology [37]	7 (2.6 %)	56 (20.7 %)	208 (76.7 %)	271
Non-Cardiac Surgery [38]	17 (11.6 %)	52 (35.6 %)	77 (52.8 %)	146
VT & SCD [39]	12 (3.7 %)	96 (29.4 %)	219 (66.9 %)	327
Pulmonary Hypertension [40]	7 (3.9 %)	44 (24.4 %)	129 (71.7 %)	180
Total	667 (15.5 %)	1285 (30 %)	2337 (54.5 %)	4289